Intertek, a leading international provider of quality and safety solutions has received Food and Drug Administration (FDA), Maharashtra, approval to test pharmaceutical samples at its Thane laboratory. The pharmaceutical laboratory located at Thane, which is ISO 9001:2008 certified is now also FDA approved by the Maharashtra Government.
The FDA, Maharashtra is the State prime organisation of consumer protection. It has dedicated professionals working to protect, promote and enhance the health of people. It is a trusted agency to enforce the Food, Drug, and Cosmetic Act fairly, upholds safety standards, and protects consumers.
“It gives us immense pleasure to announce that our laboratory in Thane is approved by FDA. Gaining the right approvals and certifications for products is extremely vital. By doing this, the company can ensure compliance and safety. Organizations must make it a point to ensure that they have all the required approvals in place, before launching a product “says Mr. Rajesh Saigal, Managing Director, Intertek India.
“Our standard operating procedures are regularly reviewed & revised, the quality assurance systems are designed on well recognized scientific principles, controlled precisely and monitored closely to generate reliable, reproducible and dependable results. Also, our reports are written clearly and precisely to reflect our strong scientific background, utmost care & quality work with the ultimate aim of both strengthening the regulatory compliance & supporting the ethical duties of our customers.” says Rupert Crasto, General Manager, Intertek India Oil Chemical, Agri and Mineral Division.
It has been determined that the pharmaceutical industry is one of the most highly regulated industries in most countries. Here precision is of paramount importance, hence, equipment, facilities, utilities, processes and process installations must all be qualified and validated. Intertek laboratories are equipped with most sophisticated equipments and manned by very high quality staff, providing the results in time with utmost accuracy.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
